Literature DB >> 22913165

General anesthesia for caesarean delivery in a pregnant woman affected by acute myocardial infarction.

L Frassanito1, S Vagnoni, B A Zanfini, S Catarci, S Maggiore, G Draisci.   

Abstract

Acute myocardial infarction rarely occurs in women during childbearing age (1:20,000), but maternal mortality rate is high (11%). Management of pregnant woman affected by myocardial infarction could be a challenge for obstetricians, cardiologists and anesthetists. In this report, we present the management of a 36 years-old nulliparous woman affected from hypertension and dyslipidemia, who experienced acute myocardial infarction at 25th gestational week and was scheduled for caesarean delivery at 35th week. General anesthesia for cesarean section was conducted using sevoflurane and remifentanil target controlled infusion (TCI); the patient was monitored with ECG, pulse oximetry, invasive blood pressure, haemodynamic measurement by lithium dilution cardiac output (LiDCO plus) and bispectral index. The titrated use of remifentanil and the close control of hemodynamic parameters by LiDCO plus monitoring may contribute to improve maternal outcome and newborn well-being in the management of general anesthesia for caesarean section.

Entities:  

Mesh:

Year:  2012        PMID: 22913165

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  Goal-directed Fluid Therapy May Improve Hemodynamic Stability of Parturient with Hypertensive Disorders of Pregnancy Under Combined Spinal Epidural Anesthesia for Cesarean Delivery and the Well-being of Newborns.

Authors:  Wei Xiao; Qing-Fang Duan; Wen-Ya Fu; Xin-Zuo Chi; Feng-Ying Wang; Da-Qing Ma; Tian-Long Wang; Lei Zhao
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

2.  Myocardial infarction in a pregnant woman revealing a transitional deficit in protein S: a rare case report.

Authors:  Souleymane Diakite; Fatima Zohra Radi; Jamila Zarzur; Mohamed Cherti
Journal:  Pan Afr Med J       Date:  2019-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.